Larka

Business Impact

Every week, discover in a precise and easy way how your business has been impacted by the recent developments in the bio/pharma industry. Subscribe!

 
Biz_impact_block_website.jpg

Dark.JPG

19 Feb 18 Edition

New bioconjugation method developed for ADCs

White.JPG

12 Fev 18 Edition

Big supply contract for biologics

White.JPG

5 Fev 18 Edition

New multi-billion acquisition

Dark.JPG

29 Jan 18 Edition

Warning Letters also hit Australian CMOs

Blue.JPG

22 Jan 18 Edition

More bio captive capacities coming soon

Blue.JPG

15 Jan 18 Edition

European CDMO is granted a supply agreement in China

Dark.JPG

8 Jan 18 Edition

Newly-approved cell therapy facility for third parties locates in Israel

Blue.JPG

2 Jan 18 Edition

New Warning Letters for Indian sites

White.JPG

25 Dec 17 Edition

Gene therapy manufacturing is taking off

Dark.JPG

18 Dec 17 Edition

South Korea & China on the move

White.JPG

11 Dec 17 Edition

New investments for sterile manufacturing

Blue.JPG

4 Dec 17 Edition

New gene therapy capacity on the market

White.JPG

27 Nov 17 Edition

South Korea well positioned in the biosimilar battle

Dark.JPG

20 Nov 17 Edition

New opportunities for drug delivery service providers

Blue.JPG

13 Nov 17 Edition

More mAb capacity in the US and EU

Dark.JPG

6 Nov 17 Edition

Asia presenting new alternatives for bio manufacturing

White.JPG

30 Oct 17 Edition

Serialisation being handled

Dark.JPG

23 Oct 17 Edition

Generic market in turmoil

Blue.JPG

16 Oct 17 Edition

CMOs buying new sites from Big Pharma

White.JPG

9 Oct 17 Edition

New biomanufaturing capacities emerge

Blue.JPG

2 Oct 17 Edition

Bioconjugation attracts new investments

Diapositive1.JPG

25 Sep 17 Edition

Big CDMO player goes bio